Nov. 7, 2020 – Currently available medication-assisted treatments for opioid use disorder include methadone, buprenorphine and naltrexone. According to Sauvé, methadone allows those with opioid use disorder to discontinue heroin use without experiencing withdrawal symptoms. It is available through specialty clinics, to which patients must make daily visits, and is linked to an increased risk for respiratory depression. Buprenorphine has appeared associated with active withdrawal symptoms among individuals currently using prescription opioids or heroin, so Sauvé emphasized that patients should be experiencing at least some mild withdrawal prior to starting buprenorphine. Although specialty licensing for the prescriber is required, it does not need to be administered at specialty clinics, and the risk for respiratory depression is lower compared to methadone.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…